Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive128AccountSocial
MARKETSINVESTLIVE128
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
  1. Biotech

KT-621 Week 16 EASI-75 advantage over placebo



Chance

55%

55%

43%

43%

30%

30%

2 more

-50-2502550Nov 18Nov 19Nov 20Nov 21
$6,486 vol
More Financials Markets

Trending Financials markets

Who will be the next CEO of NVIDIA?S&P close price end of 2026?Nasdaq-100 close price end of 2026?Where will Jensen Huang work next this year?Will the S&P finish positive this year?How low will the S&P get this year?When will NVIDIA announce its next permanent CEO?Wendy's Monthly Credit Card Spend in November 2026

Financials hub

All Financials markets
KT-621 Week 16 EASI-75 advantage over placebo

Above 20.0 pp

Odds
94% chance
Max payout
Jan 7, 2027
$0